相关实验视频
Updated: Jul 15, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.3K
在小鼠模型中,Broncho-Vaxom细菌溶解酸通过乙增强预防喘
Seung-Hwa Lee1, Ha-Jung Kim2, So-Yeon Lee3
1Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, South Korea.
概括
支气管-Vaxom (BV) 口服治疗通过促进调节性T (Treg) 细胞和酸盐生产,减少了小鼠的过敏气道炎症,为其免疫调节作用提供了潜在的机制.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物组研究的研究.
- 呼吸系统药物 呼吸系统药物
背景情况:
- 支气管-Vaxom (BV) 在临床上用于治疗过敏气道炎症和慢性支气管炎.
- 在BV的肠介导免疫效应背后的精确机制尚未完全理解.
- 研究口服免疫调节剂,肠道微生物群代谢物和免疫反应之间的联系至关重要.
研究的目的:
- 探索口服支气管 (BV) 对肠道和全身短链脂肪酸 (SCFA) 的影响.
- 在过敏性喘的小鼠模型中评估BV对免疫反应的影响.
- 阐明BV在过敏呼吸道炎症中的治疗作用的潜在机制.
主要方法:
- 使用卵蛋白 (OVA) 敏感化和吸入挑战,建立了一个喘小鼠模型.
- 口服BV是在喘诱导前15天内服用的.
- 分析包括喘表型,肠道和全身免疫细胞种群,以及阴和血液中的SCFA水平.
主要成果:
- BV治疗显著抑制了气道的高反应性,IgE的产生和肺炎.
- 干白素-13水平下降,而TGF-β表达在接受VB治疗的小鼠的肺部增加.
- 在小肠中观察到调节性T (Treg) 细胞数量的增加,同时在体和血清中酸盐水平升高. 乙酸盐水平与呼吸道过敏反应负相关,与TGF-β表达呈正相关.
结论:
- 在小鼠模型中,口服BV可以减轻过敏气道炎症.
- 增强的Treg细胞增殖和增加的酸盐生产似乎是BV治疗作用的关键机制.
- 这项研究提供了通过口服细菌溶解物对肠介导的免疫调节的见解.
相关概念视频
01:20Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
01:29Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Antiasthma Drugs: Methylxanthines
261
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
261